聚合物偶联 IL-15 NKTR-255 与 CAR-T 细胞治疗协同激活内源性抗肿瘤免疫并改善肿瘤控制 NKTR-255, a polymer-conjugated IL-15, synergizes with CAR-T cell therapy to activate endogenous anti-tumor immunity and improve tumor control. PubMed 2025/12/15 发表bioRxiv 靶点:CD19靶点:ROR1技术:CAR-T技术:NK 细胞肺癌B 细胞恶性肿瘤